Here’s Our Story
IRUBIS GmbH is founded and wins the Medical Valley Award. The team soon develops a silicon crystal for infrared spectroscopy.
Our technological proof of concept is finalized: online monitoring of glucose with IRUBIS silicon crystal and mid-infrared spectrometer. A prototype with higher system sensitivity is developed.
Our Monipa prototype is validated at three biopharma companies.
IRUBIS is one of the winners of the H2020 EIC Accelerator Pilot and uses this momentum to develop additional projects and continue to validate the Monipa prototype in the biopharma industry.
Market entry with Monipa: Online monitoring in upstream bioprocessing of metabolite and nutrient concentration and for automated glucose control.
IRUBIS, has raised EUR 2.8m in a seed financing round. The round was led by High-Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed Investors with the participation of EIC Fund, the Initiative for Industrial Innovators and a number of business angels from the biotech industry or Munich startup scene.